Javier, Chemie .

HRN: 16-76-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2024
CEFUROXIME 1.5GM (VIAL)
11/11/2024
11/11/2024
IV
1.5g
On Call Or
For CS
Waiting Final Action 
11/11/2024
CEFUROXIME 500MG (TAB)
11/11/2024
11/18/2024
ORAL
500MG
BID X 7 Days
Post Partum Prophylaxis
Waiting Final Action 
11/11/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/11/2024
11/11/2024
IV
500mg
Q8
IUFD
Waiting Final Action 
11/11/2024
METRONIDAZOLE 500MG (TAB)
11/11/2024
11/18/2024
ORAL
500mg
BID X 7 Days
S/p Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: